Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

NCT06243744
completednot_applicable

Evaluation of the Use of the Renuvion APR System in the Labia

NCT05323630
completednot_applicable

A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System

NCT05665335
completednot_applicable

Post-Market Lower Eyelid Treatment With Renuvion in Greece

NCT05605691
completednot_applicable

Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery

NCT05093049

Clinical Trials (5)

Showing 5 of 5 trials
NCT06243744Not Applicable

Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

Completed
NCT05323630Not Applicable

Evaluation of the Use of the Renuvion APR System in the Labia

Completed
NCT05665335Not Applicable

A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System

Completed
NCT05605691Not Applicable

Post-Market Lower Eyelid Treatment With Renuvion in Greece

Completed
NCT05093049Not Applicable

Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5